Information
NOVADOZ PHARMACEUTICALS LLC Recalls Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz
This is a Class III recall. This product is unlikely to cause adverse health reactions but violates FDA regulations.
Source: FDA
InfoRecall #D-0300-2026Drug / Pharmaceutical
NOVADOZ PHARMACEUTICALS LLC Recalls Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz
NOVADOZ PHARMACEUTICALS LLC · Class III — Regulatory
Product Description
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
Reason for Recall
Failed Impurities/Degradation Specifications
FDA Classification
Class III — Regulatory
A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Distribution
US Nationwide.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A regulatory compliance recall has been issued for a pharmaceutical product from NOVADOZ PHARMACEUTICALS LLC. The FDA classified this as Class III on December 15, 2025. Failed Impurities/Degradation Specifications. It was distributed in US Nationwide. While this classification indicates a low probability of adverse health effects, consumers should be aware of the recall and follow any instructions from the manufacturer.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.